Post Market Surveillance for Infanrix™

Evaluation of Safety and Efficacy Through Post Market Surveillance for Infanrix™, the DTaP Mixed Vaccine

The purpose of this study was to investigate the following questions through post-marketing surveillance:

• Unknown/Unexpected adverse events and the serious adverse events.
• The circumstances in which the adverse events occurred under the practical application.
• Factors considered to have influence on safety.
• Factors considered to have influence on efficacy.
• Miscellaneous - Facts about mechanism, efficacy and safety which were not clearly known due to the inherent problems of the drugs.

Inclusion Criteria:

All children receiving Infanrix™ were eligible for this survey.

Exclusion Criteria: